XML 91 R82.htm IDEA: XBRL DOCUMENT v3.22.2
BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Narrative (Details)
$ / shares in Units, $ in Thousands
May 02, 2022
USD ($)
$ / shares
shares
Dec. 31, 2021
USD ($)
test
Jun. 30, 2022
USD ($)
Jun. 23, 2021
May 03, 2021
Business Acquisition [Line Items]          
Contingent consideration   $ 359,021 $ 311,785    
OmicEra          
Business Acquisition [Line Items]          
Business acquisition, equity interest issued or issuable (in shares) | shares 265,186        
Shares issued, price per share (in usd per share) | $ / shares $ 55.78        
Contingent payment obligations $ 6,000        
Contingent consideration 4,600        
Developed technology $ 10,000        
Weighted-average remaining useful life of finite-lived intangible asset (in years) 16 years        
PFS Genomics          
Business Acquisition [Line Items]          
Asset acquisition, percentage of interest acquired         90.00%
Remaining interest in PFS       10.00%  
PreventionGenetics acquisition          
Business Acquisition [Line Items]          
Number of tests provided | test   5,000